Literature DB >> 26052200

Risk stratification in submassive pulmonary embolism via alveolar-arterial oxygen gradient.

O Ince1, N Altintas2, S Findik1, M Sariaydin1.   

Abstract

AIM: This study investigated the utility of the alveolar-arterial (AaDO2) gradient in predicting the short-term prognosis of submassive pulmonary embolism (PE).
MATERIAL AND METHODS: This study retrospectively enrolled 124 patients with acute submassive PE. During the first 24 h of admission, all patients had initial artery blood gas collected under room air. Cardiac troponin T (cTn-T) was measured and on spiral computed tomography pulmonary angiography (CTPA) and echocardiography both right ventricle diameter and left ventricle diameter was calculated (RV/LV ratio). Patients who did not have objectively confirmed submassive PE and who had curative anticoagulant treatment for more than 24 hours and had a life expectancy less than 3 months were excluded from the study.
RESULTS: The best cut-off value for AaDO2 was 42.38 mmHg and using this, fourteen of 15 patients who died had AaO2 ≥ 42.38 and 71 of 109 patients who survived had a AaO2 lower than 42.38 with a sensitivity, specificity and negative predictive value (NPV) for overall deaths were 93.3%, 65.1% and 98.6% respectively. In addition, AaDO2 < 42.38 showed significant survival benefit for overall mortality rates. In this study, having high cTn-T and PaO2/ PaCO2 < 1.83 and pulmonary artery pressure > 47.5 were also an indicator of poor prognosis for patients with submasssive PE.
CONCLUSION: The AaDO2 measurement is a highly useful and simple measurement for predicting short-term prognosis in patients with submassive PE. It may be used in risk stratification of patients with submassive PE. Aggressive thrombolytic treatment strategies may be considered for patients who have AaO2 < 42.38. Hippokratia 2014; 18 (4): 333-339.

Entities:  

Keywords:  Submassive pulmonary embolism; alveolar-arterial oxygen gradient; blood arterial gases

Year:  2014        PMID: 26052200      PMCID: PMC4453807     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  35 in total

Review 1.  Pulmonary embolism: what have we learned since Virchow?: treatment and prevention.

Authors:  James E Dalen
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

2.  Differences in clinical presentation of pulmonary embolism in older vs younger patients.

Authors:  Nurdan Kokturk; I Kivilcim Oguzulgen; Nalan Demir; Koray Demirel; Numan Ekim
Journal:  Circ J       Date:  2005-08       Impact factor: 2.993

3.  The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease.

Authors:  K M McIntyre; A A Sasahara
Journal:  Am J Cardiol       Date:  1971-09       Impact factor: 2.778

4.  Derivation and validation of a prognostic model for pulmonary embolism.

Authors:  Drahomir Aujesky; D Scott Obrosky; Roslyn A Stone; Thomas E Auble; Arnaud Perrier; Jacques Cornuz; Pierre-Marie Roy; Michael J Fine
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

5.  Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism.

Authors:  Jacques Donzé; Grégoire Le Gal; Michael J Fine; Pierre-Marie Roy; Olivier Sanchez; Franck Verschuren; Jacques Cornuz; Guy Meyer; Arnaud Perrier; Marc Righini; Drahomir Aujesky
Journal:  Thromb Haemost       Date:  2008-11       Impact factor: 5.249

6.  The mechanisms of abnormal gas exchange in acute massive pulmonary embolism.

Authors:  G E D'Alonzo; J S Bower; P DeHart; D R Dantzker
Journal:  Am Rev Respir Dis       Date:  1983-07

7.  Pulmonary embolism: diagnosis with electron-beam CT.

Authors:  C L Teigen; T P Maus; P F Sheedy; C M Johnson; A W Stanson; T J Welch
Journal:  Radiology       Date:  1993-09       Impact factor: 11.105

Review 8.  Evidence-based emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism?

Authors:  Andrew Worster; Camala Smith; Shawna Silver; Michael D Brown
Journal:  Ann Emerg Med       Date:  2007-04-20       Impact factor: 5.721

9.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983

Review 10.  Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis.

Authors:  David Jiménez; Fernando Uresandi; Remedios Otero; José Luis Lobo; Manuel Monreal; David Martí; Javier Zamora; Alfonso Muriel; Drahomir Aujesky; Roger D Yusen
Journal:  Chest       Date:  2009-05-22       Impact factor: 9.410

View more
  3 in total

Review 1.  Potential role of systemic thrombolysis in acute submassive intermediate risk pulmonary embolism: review and future perspectives.

Authors:  Mohamed Teleb; Mateo Porres-Aguilar; Javier E Anaya-Ayala; Carlos Rodriguez-Castro; Mateo Porres-Muñoz; Debabrata Mukherjee
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-02-09

2.  Rapid on-site evaluation of routine biochemical parameters to predict right ventricular dysfunction in and the prognosis of patients with acute pulmonary embolism upon admission to the emergency room.

Authors:  Dong Jia; Fan Liu; Qin Zhang; Guang-Qiao Zeng; Xue-Lian Li; Gang Hou
Journal:  J Clin Lab Anal       Date:  2017-11-21       Impact factor: 2.352

3.  Is Bedside End-Tidal CO2 Measurement a Screening Tool to Exclude Pulmonary Embolism in Emergency Department?

Authors:  Metin Ozdemir; Bedriye Muge Sonmez; Fevzi Yilmaz; Aykut Yilmaz; Murat Duyan; Seval Komut
Journal:  J Clin Med Res       Date:  2019-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.